Clinical utilities of aromatase inhibitors in breast cancer
Saranya Chumsri Department of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, USA Abstract: Aromatase is an enzyme that converts testosterones to estrogens. Inhibition of this enzyme has been shown to have several clinical utilities in breast cancer. Currently, there are three aroma...
Saved in:
Main Author: | Chumsri S (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2015-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Aromatase inhibitor strategies in metastatic breast cancer
by: Heather L McArthur, et al.
Published: (2009) -
Long-term safety of aromatase inhibitors in the treatment of breast cancer
by: Jean-Marc A Nabholtz
Published: (2008) -
Potential utility of natural products as regulators of breast cancer-associated aromatase promoters
by: Walker Larry A, et al.
Published: (2011) -
What influences aromatase inhibitor continuation intention among breast cancer survivors?
by: Young Kyung Seo, et al.
Published: (2021) -
Systematic review of economic evaluations of aromatase inhibitors in estrogen receptor-positive breast cancer: quality evaluation
by: Maha F. Althuwaibi, et al.
Published: (2023)